Summary

It has been shown that renal denervation (RDN; also called renal nerve ablation) can lower blood pressure (BP) in patients with resistant hypertension and that this effect can be maintained to more than 24 months [Symplicity HTN-1 Investigators. Hypertens 2011]. However, there are few data about the effect of RDN on organs and the sympathetic nervous system. This article presents data from a study to determine whether RDN has an effect on inflammation and endothelial function in patients with resistant hypertension.